BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 12685321)

  • 1. [The role of human papillomavirus in carcinogenesis of cervical cancer and vaccination for HPV].
    Kariya M; Fujii S
    Uirusu; 2002 Dec; 52(2):287-93. PubMed ID: 12685321
    [No Abstract]   [Full Text] [Related]  

  • 2. Multistep carcinogenesis and genital papillomavirus infection. Implications for diagnosis and vaccines.
    Rangel LM; Ramírez M; Torroella M; Pedroza A; Ibarra V; Gariglio P
    Arch Med Res; 1994; 25(2):265-72. PubMed ID: 7919824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of preventive human papillomavirus vaccination.
    Lehtinen M; Paavonen J
    Int J STD AIDS; 2003 Dec; 14(12):787-92. PubMed ID: 14678583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of viral infection with human papillomavirus-HPV in carcinogenesis of the uterine cervix].
    Kwaśniewska A
    Postepy Hig Med Dosw; 1997; 51(5):547-65. PubMed ID: 9489454
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer.
    Santin AD; Bellone S; Gokden M; Cannon MJ; Parham GP
    N Engl J Med; 2002 May; 346(22):1752-3. PubMed ID: 12037163
    [No Abstract]   [Full Text] [Related]  

  • 6. [Viruses and cervical cancers].
    Mathevet P
    Rev Prat; 2001 Sep; 51(13):1413-6. PubMed ID: 11601069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HPV vaccination--a possibility for prevention of cervical cancer].
    Paavonen J
    Duodecim; 2002; 118(21):2159-60. PubMed ID: 12486951
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of human papillomavirus vaccines in cervical neoplasia.
    Stern PL; Faulkner R; Veranes EC; Davidson EJ
    Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):783-99. PubMed ID: 11563873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus and cervical carcinogenesis.
    Stanley MA
    Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):663-76. PubMed ID: 11563866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention strategies of cervical cancer in the HPV vaccine era.
    Bosch X; Harper D
    Gynecol Oncol; 2006 Oct; 103(1):21-4. PubMed ID: 16919714
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins.
    Davidson EJ; Boswell CM; Sehr P; Pawlita M; Tomlinson AE; McVey RJ; Dobson J; Roberts JS; Hickling J; Kitchener HC; Stern PL
    Cancer Res; 2003 Sep; 63(18):6032-41. PubMed ID: 14522932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus in carcinogenesis of cervical cancer.
    de Silva NR; Mendis L; Perera N
    Ceylon Med J; 1999 Mar; 44(1):45-7. PubMed ID: 10643100
    [No Abstract]   [Full Text] [Related]  

  • 13. [Perspectives for the development of vaccines and immunotherapy against cervico-uterine cancer].
    Guzmán-Rojas L; Alcocer-González JM; Madrid-Marina V
    Salud Publica Mex; 1998; 40(1):38-46. PubMed ID: 9567657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillomavirus-like particle vaccines for cervical cancer.
    Schiller JT
    Mol Med Today; 1999 May; 5(5):209-15. PubMed ID: 10322313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biology of the papillomavirus infections: V. Vaccine developments].
    Seilles E; Riethmuller D; Mougin C
    Ann Biol Clin (Paris); 1999; 57(5):517-24. PubMed ID: 10518053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7.
    Daemen T; Regts J; Holtrop M; Wilschut J
    Gene Ther; 2002 Jan; 9(2):85-94. PubMed ID: 11857066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus vaccines for the prevention and treatment of cervical cancer.
    Tomson TT; Roden RB; Wu TC
    Curr Opin Investig Drugs; 2004 Dec; 5(12):1247-61. PubMed ID: 15648945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer, human papillomavirus, and vaccination.
    Lowndes CM; Gill ON
    BMJ; 2005 Oct; 331(7522):915-6. PubMed ID: 16239668
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
    Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH
    Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.